[1]
“FROM SERUM DYSLIPIDEMIA TO MACROPHAGE LIPID REMODELING IN VISCERAL LEISHMANIASIS: CHOLESTEROL TRAFFICKING, IMMUNOMETABOLIC REPROGRAMMING, AND THERAPEUTIC OPPORTUNITIES”, ISIRJBMS, vol. 3, no. 5, pp. 45–55, Oct. 2026, Accessed: Nov. 17, 2026. Available: https://isirpublisher.com/index.php/isirjbms/article/view/48